Last reviewed · How we verify
Aspirin 100mg
Aspirin 100mg, marketed by Azienda Ospedaliero Universitaria Maggiore della Carita, holds a well-established position in the pharmaceutical market. The key composition patent for Aspirin 100mg is set to expire in 2028, which may present a significant competitive advantage until then. The primary risk is the potential increase in generic competition following the patent expiry in 2028.
At a glance
| Generic name | Aspirin 100mg |
|---|---|
| Also known as | Aspirin protect, Aspirin enteric coated, Aspirin, Oxygen therapy, antiviral treatment and other support treatments |
| Sponsor | Azienda Ospedaliero Universitaria Maggiore della Carita |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis (PHASE4)
- IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome (PHASE4)
- Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination. (PHASE1)
- Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement (PHASE4)
- Omega-3 Pufa and Aspirin as Adjunctive Therapy in Treatment of Smoker Patients With Stage Iii Periodontitis (NA)
- Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients (PHASE2)
- Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aspirin 100mg CI brief — competitive landscape report
- Aspirin 100mg updates RSS · CI watch RSS
- Azienda Ospedaliero Universitaria Maggiore della Carita portfolio CI